MAPK10 (Mitogen-Activated Protein Kinase 10), also known as JNK3 (c-Jun N-terminal kinase 3), is a gene that encodes a member of the MAPK family of serine/threonine kinases. The protein is predominantly expressed in the central nervous system and plays critical roles in stress responses, neuronal apoptosis, synaptic plasticity, and neurodegeneration. MAPK10/JNK3 is one of three JNK isoforms (JNK1, JNK2, JNK3), with JNK3 being neuron-specific.
The MAPK10 gene is located on chromosome 5q36.3 and encodes a 464-amino acid protein that belongs to the MAPK family. Unlike JNK1 and JNK2, which are ubiquitously expressed, MAPK10/JNK3 is primarily expressed in neurons, making it a key regulator of neuronal stress responses and a potential therapeutic target for neurodegenerative diseases.
¶ Gene Structure and Organization
- Chromosome: 5q36.3
- Gene ID: 5602
- Genomic position: Approximately 179,500,000-179,600,000 (GRCh38)
- Strand: Minus/antisense strand
- Gene family: MAPK family, JNK subfamily
The MAPK10 gene consists of multiple exons:
- Exon count: 21 exons
- Alternative splicing: Produces multiple isoforms
- Promoter elements: Contains neuronal-specific regulatory elements
MAPK10 generates multiple protein isoforms through alternative splicing:
- JNK3α1: Full-length isoform (464 aa)
- JNK3α2: Alternative splice variant
- JNK3β: Shorter isoform with different C-terminus
- Brain regions: Differential expression in cortex, hippocampus, cerebellum
- Cell type specificity: Neuron-specific expression
- Development: Different isoforms at different developmental stages
- Length: 464 amino acids
- Molecular weight: ~52 kDa
- Isoelectric point: ~6.5
¶ Domain Organization
¶ Kinase Domain
- Location: N-terminal region (residues 1-300)
- Function: Catalytic kinase activity
- Motifs: Contains typical kinase motifs including:
- ATP-binding pocket (Lysine-93)
- Activation loop (Thr-221, Tyr-223)
- Substrate-binding region
- Location: residues 300-464
- Function: Regulatory and interaction domains
- JNK interaction domain: Binds upstream activators
- Activation loop: Thr-221 and Tyr-223 phosphorylation required for activity
- Upstream kinases: MKK4 and MKK7 phosphorylate JNK3
- ** phosphatases**: Dephosphorylation inactivates JNK3
- Ubiquitination: Regulates protein stability
- Sumoylation: Affects localization and function
- Acetylation: Modulates activity
MAPK10/JNK3 is activated by cellular stress:
- Oxidative stress: ROS, peroxides
- DNA damage: UV, ionizing radiation
- Endoplasmic reticulum stress: Protein misfolding
- Cytokines: TNF-α, IL-1β
- Glutamate excitotoxicity: Excessive glutamate signaling
- Upstream activators: MAPKKK (MEKK1-4, MLK)
- MAPKK: MKK4 and MKK7 phosphorylate JNK3
- Downstream targets: Transcription factors, Bcl-2 family
JNK3 plays a central role in neuronal death:
- c-Jun phosphorylation: Activates pro-apoptotic gene expression
- Bcl-2 family: Phosphorylates Bim, BAD
- Mitochondrial pathway: Initiates intrinsic apoptosis
- Fas/FasL pathway: Death receptor signaling
- Transcription activation: Phosphorylates c-Jun, ATF2
- Mitochondrial dysfunction: Alters membrane potential
- Caspase activation: Initiates caspase cascade
- Gene expression: Pro-apoptotic gene transcription
JNK3 regulates synaptic function:
- AMPA receptor trafficking: Modifies receptor insertion
- Dendritic spine morphology: Affects spine shape
- Synaptic signaling: Modulates downstream effectors
- Endocytosis: Promotes receptor internalization
- Synaptic weakening: Contributes to LTD
- Memory consolidation: Role in memory processes
JNK3 contributes to neuroinflammation:
- Pro-inflammatory genes: Activates NF-κB pathway
- Glial activation: Modulates microglia and astrocytes
- Chemokine expression: Regulates inflammatory cell recruitment
JNK3 is heavily implicated in AD pathogenesis:
- Aβ-induced activation: Oligomeric Aβ activates JNK3
- Tau phosphorylation: JNK3 phosphorylates tau at pathological sites
- Synaptic dysfunction: Contributes to synaptic loss
- Neuronal death: Pro-apoptotic effects in AD neurons
- Post-mortem brain: Elevated JNK3 activation in AD brain
- Animal models: JNK3 deletion protects against Aβ toxicity
- Therapeutic targeting: JNK inhibitors show promise
JNK3 plays roles in PD:
- Oxidative stress: 6-OHDA, MPTP activate JNK3
- α-Synuclein toxicity: Synuclein aggregates activate JNK
- Mitochondrial dysfunction: Complex I inhibitors activate JNK
- Neuroprotection: JNK inhibitors protect dopaminergic neurons
- Animal models: JNK3 knockout resistant to MPTP
- Clinical trials: JNK inhibitors in development
¶ Stroke and Ischemia
JNK3 contributes to ischemic injury:
- Energy failure: Activates stress pathways
- Excitotoxicity: Glutamate activates JNK3
- Inflammation: Contributes to inflammatory damage
- Neuroprotection: JNK inhibitors reduce infarct size
- Time window: Early intervention critical
- Preclinical results: Promising neuroprotection
JNK3 is involved in motor neuron disease:
- SOD1 mutants: Activate JNK3 pathway
- Excitotoxicity: Glutamate-induced activation
- Axonal degeneration: Contributes to axonal loss
- JNK inhibitors: Protect motor neurons in models
- Gene therapy: Targeting JNK3 expression
JNK3 contributes to HD pathology:
- Mutant huntingtin: Activates JNK3 pathway
- Transcriptional dysregulation: c-Jun phosphorylation affects genes
- Neuronal dysfunction: Contributes to disease progression
- Post-mortem brain: Elevated JNK3 in HD brain
- Animal models: JNK3 deletion improves phenotype
- Therapeutic potential: JNK inhibition strategies
MAPK10 operates in the canonical MAPK cascade:
Stress signals → MAPKKK (MEKK1-4) → MAPKK (MKK4/7) → MAPK10/JNK3 → Downstream targets
- c-Jun: AP-1 transcription factor component
- ATF2: Activating transcription factor 2
- p53: Tumor suppressor, apoptosis regulator
- NF-κB: Inflammatory gene expression
- Bim: Pro-apoptotic BH3-only protein
- BAD: Pro-apoptotic regulator
- Bcl-2: Anti-apoptotic protein (indirect effects)
- AMPA receptor subunits: Modulates trafficking
- PSD-95: Synaptic scaffolding
- Synaptic vesicles: Regulates neurotransmitter release
| Partner | Interaction | Function |
|---------|-------------|----------|
| MKK4 | Phosphorylation | Activates JNK3 |
| MKK7 | Phosphorylation | Activates JNK3 |
| MEKK1 | Phosphorylation | MAPKKK activator |
| MLK3 | Phosphorylation | MAPKKK activator |
- c-Jun: Primary substrate
- ATF2: Stress response transcription factor
- PMS2: DNA repair protein
- SAB: Synaptic scaffold protein
- JIP proteins: JNK-interacting proteins
- JNK scaffold: Assemble signaling complexes
- β-arrestin: Scaffold for GPCR signaling
Mapk10/Jnk3-deficient mice exhibit:
- Viable and fertile: Normal development
- Neuronal protection: Resistant to excitotoxic death
- Reduced apoptosis: Protected from various insults
- Behavioral changes: Altered learning and memory
Transgenic overexpression studies show:
- Neurodegeneration: Induces neuronal death
- Parkinsonism: MPTP sensitivity
- Alzheimer's phenotype: Amyloid-related pathology
- Stroke sensitivity: Exacerbates ischemic damage
- Neuron-specific deletion: Tissue-specific knockouts
- Inducible systems: Temporal control of expression
- Disease models: Conditional mutant expression
JNK3 is a therapeutic target:
- SP600125: First-generation JNK inhibitor
- JNK-IN-8: More specific JNK inhibitor
- CC-90009: Brain-penetrant JNK inhibitor
- Neuroprotection: Prevent neuronal death
- Anti-inflammation: Reduce neuroinflammation
- Synaptic preservation: Maintain synaptic function
Potential clinical uses:
- Alzheimer's disease: Slow progression
- Parkinson's disease: Neuroprotection
- Stroke: Reduce secondary damage
- ALS: Motor neuron protection
- Isoform specificity: Achieving JNK3 selectivity
- Brain penetration: Delivery to CNS
- Toxicity: Off-target effects
MAPK10 genetic variations include:
- Promoter variants: May affect expression
- Coding variants: Some may alter kinase activity
- Non-coding variants: Regulatory effects
Polymorphisms have been linked to:
- Alzheimer's disease: Some variants affect risk
- Parkinson's disease: Variable associations
- Stroke susceptibility: Post-ischemic outcomes
MAPK10 is evolutionarily conserved:
- Mammals: High conservation
- Vertebrates: Present in all vertebrates
- Invertebrates: JNK homologs present
The JNK family includes:
- MAPK10/JNK3: Neuron-specific
- MAPK8/JNK1: Ubiquitous
- MAPK9/JNK2: Ubiquitous
MAPK10 (JNK3) is a neuronal-specific stress-activated kinase with critical roles in:
- Apoptosis: Central regulator of neuronal death
- Synaptic plasticity: Modulates synaptic function
- Neurodegeneration: Implicated in AD, PD, HD, ALS
- Stress response: Responds to various cellular stresses
- Inflammation: Contributes to neuroinflammation
Understanding MAPK10 function provides insights into:
- Neuronal death mechanisms
- Neurodegenerative disease pathogenesis
- Therapeutic targeting strategies
- Stress response biology
The neuron-specific expression of JNK3 makes it an attractive target for treating neurological disorders while potentially minimizing peripheral side effects.